Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Paramorphine
2. 115-37-7
3. Thebain
4. 3-o-methyl-oripavin
5. 4,5alpha-epoxy-3,6-dimethoxy-17-methyl-6,8-morphinadien
6. 2p9mkg8gx7
7. (5r,9r,13s)-4,5-epoxy-3,6-dimethoxy-9alpha-methyl-6,8-morphinadien
8. Chebi:9519
9. (4r,7ar,12bs)-7,9-dimethoxy-3-methyl-2,4,7a,13-tetrahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline
10. Ncgc00160239-01
11. Dsstox_cid_26099
12. Dsstox_rid_81337
13. Dsstox_gsid_46099
14. (5alpha)-6,7,8,14-tetradehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan
15. 3,6-dimethoxy-17-methyl-6,7,8,14-tetradehydro-4,5alpha-epoxymorphinan
16. Cas-115-37-7
17. Einecs 204-084-1
18. Unii-2p9mkg8gx7
19. Tebaine
20. Thenaine
21. Kodein
22. Dea No. 9333
23. Thebaine, Powder
24. Ncgc00247709-01
25. Thebaine [mi]
26. Thebaine [who-dd]
27. Schembl37580
28. Chembl403893
29. Ids-nt-002
30. Dtxsid7046099
31. Schembl19880976
32. Thebaine 0.1 Mg/ml In Methanol
33. Bdbm224032
34. Tox21_111751
35. Tox21_112863
36. Zinc53199482
37. Morphinan, 6,7,8,14-tetradehydro-4,5-alpha-epoxy-3,6-dimethoxy-17-methyl-
38. C06173
39. Codeine Monohydrate Impurity G [ep Impurity]
40. Q63392872
41. Oxycodone Hydrochloride Impurity F [ep Impurity]
42. Thebaine, European Pharmacopoeia (ep) Reference Standard
43. Codeine Hydrochloride Dihydrate Impurity G [ep Impurity]
44. Codeine Phosphate Hemihydrate Impurity G [ep Impurity]
45. Codeine Phosphate Sesquihydrate Impurity G [ep Impurity]
46. 6,7,8,14-tetradehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan
47. Hydrocodone Hydrogen Tartrate 2.5-hydrate Impurity I [ep Impurity]
48. (5.alpha.)-6,7,8,14-tetradehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan
49. Morphinan, 6,7,8,14-tetradehydro-4,5-epoxy-3,6-dimethoxy-17-methyl-,(5.alpha.)-
50. Thebaine Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material
51. D4r
| Molecular Weight | 311.4 g/mol |
|---|---|
| Molecular Formula | C19H21NO3 |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 311.15214353 g/mol |
| Monoisotopic Mass | 311.15214353 g/mol |
| Topological Polar Surface Area | 30.9 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 585 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
Convulsants
Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A CAS-115-37-7 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-115-37-7, including repackagers and relabelers. The FDA regulates CAS-115-37-7 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-115-37-7 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-115-37-7 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-115-37-7 supplier is an individual or a company that provides CAS-115-37-7 active pharmaceutical ingredient (API) or CAS-115-37-7 finished formulations upon request. The CAS-115-37-7 suppliers may include CAS-115-37-7 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-115-37-7 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CAS-115-37-7 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CAS-115-37-7 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CAS-115-37-7 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CAS-115-37-7 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CAS-115-37-7 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CAS-115-37-7 suppliers with NDC on PharmaCompass.
CAS-115-37-7 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-115-37-7 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-115-37-7 GMP manufacturer or CAS-115-37-7 GMP API supplier for your needs.
A CAS-115-37-7 CoA (Certificate of Analysis) is a formal document that attests to CAS-115-37-7's compliance with CAS-115-37-7 specifications and serves as a tool for batch-level quality control.
CAS-115-37-7 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-115-37-7 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-115-37-7 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-115-37-7 EP), CAS-115-37-7 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-115-37-7 USP).
LOOKING FOR A SUPPLIER?
